Intermediate susceptibility dose-dependent breakpoints for high dose rifampicin, isoniazid and pyrazinamide treatment in multidrug-resistant tuberculosis programmes.
Series / Report no.
Open Access
Type
Article
Language
Date
2018
Research Projects
Organizational Units
Journal Issue
Title
Intermediate susceptibility dose-dependent breakpoints for high dose rifampicin, isoniazid and pyrazinamide treatment in multidrug-resistant tuberculosis programmes.
Translated Title
Published in
Clin Infect Dis 2018; 67(11):1743-9